HUMANRIB
HumanRib: metal ion binding - stucture - function relations of the human CPEB3 ribozyme
| Coordinatore | UNIVERSITAET ZUERICH
Organization address
address: Raemistrasse 71 contact info |
| Nazionalità Coordinatore | Switzerland [CH] |
| Totale costo | 144˙466 € |
| EC contributo | 144˙466 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2012-IEF |
| Funding Scheme | MC-IEF |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-10-01 - 2015-03-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITAET ZUERICH
Organization address
address: Raemistrasse 71 contact info |
CH (ZURICH) | coordinator | 144˙466.66 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Until recently, ribozymes (enzymes composed of folded RNA) were found only in lower organisms. The discovery of the human CPEB3 ribozyme, related to the Hepatitis Delta Virus one, was an enormous breakthrough, which gave rise to numerous scientific questions. In the scope of this project, I want to answer the most emerging ones; I aim to solve the NMR structure of the whole CPEB3 ribozyme (we already have some promising preliminary results), as well as to crystallize it (in collaboration with another group) and compare the solution NMR and solid state X-ray structure. To understand changes in dynamics and folding of the ribozyme in the presence of Mg(II) (the natural cofactor), and also in the presence of other metal ions, single-molecule FRET (Förster Resonance Energy Transfer) experiments will be performed. As a long–term goal (after the repatriation to my home University), I will use NMR to characterize specific metal binding sites, structural and thermodynamic changes within the ribozyme upon the addition of metal ions. A big advantage of this project is that the ribozyme will be studied as a whole unit and not cut down into smaller parts. Although much more challenging, this will give a complete and clear view on the metal ion binding - structure - function relations. I am convinced that the proposed interdisciplinary project, which combines structural biology with coordination chemistry, is an exciting and necessary field of study, crucial for understanding not only the complicated structure and pathway of metal – mediated cleavage of the only known human ribozyme, but also for providing insight into its evolutional background, after being compared to the mechanism in which the viral HDV ribozyme functions.'